Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmaxim Brands AB
AB
Active
Org 5591116081
Norra Svedengatan 30, 582 73
Linköping
Leasing of intellectual property and similar products, except copyrighted works
·
NACE 7740
Est. 2017 · 9 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Leasing of intellectual property and similar products, except copyrighted works
/
Pharmaxim Brands AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
6M
5M
3M
2M
0M
2020: 0M
0M
2020
2021: 4M
4M
2021
2022: 3M (-25% vs 2021)
3M
-25%
2022
2023: 4M (+33% vs 2022)
4M
+33%
2023
2024: 5M (+25% vs 2023)
5M
+25%
2024
EBITDA
SEK millions
11M
8M
6M
3M
0M
2020: 9M
9M
2020
2021: 4M (-56% vs 2020)
4M
-56%
2021
2022: 3M (-25% vs 2021)
3M
-25%
2022
2023: 4M (+33% vs 2022)
4M
+33%
2023
2024: 5M (+25% vs 2023)
5M
+25%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
4 561
3 826
3 423
3 690
0
Staff expenses
—
—
—
—
—
EBITDA
4 561
3 826
3 423
3 688
9 071
Depreciation & amort.
−2 700
−2 700
−2 700
−2 700
−2 700
EBIT
1 861
1 126
723
988
6 371
Net financials
−55
−5
−49
−5
−746
Profit before tax
3
−5
24
983
12 620
Tax
−0
−0
−15
−204
−2 701
Net profit
3
−5
9
779
9 919
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
13 774
11 911
11 925
14 625
17 372
Equity
10 772
10 769
10 775
10 766
9 986
Long-term debt
2 987
1 126
908
932
4 486
Short-term debt
15
15
242
2 928
2 900
Total debt
3 002
1 141
1 150
3 860
7 386
Financial ratios
5-year trend
EBITDA margin
100,0 %
This company
15,8 %
Market median
This company
Market median
533% above market
2020
2024
Equity ratio
78,2 %
This company
38,2 %
Market median
This company
Market median
105% above market
2020
2024
Return on equity
0,0 %
This company
18,4 %
Market median
This company
Market median
100% below market
2020
2024
Net profit margin
0,1 %
This company
8,1 %
Market median
This company
Market median
99% below market
2020
2024
Asset turnover
0,33×
This company
1,12×
Market median
This company
Market median
71% below market
2020
2024
Debt / equity
0,28×
This company
0,62×
Market median
This company
Market median
55% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pharmaxim Brands AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
